Literature DB >> 22055239

3-Alkyl- and 3-amido-isothiazoloquinolin-4-ones as ligands for the benzodiazepine site of GABA(A) receptors.

Jakob Nilsson1, Elsebet Østergaard Nielsen2, Tommy Liljefors3, Mogens Nielsen3, Olov Sterner4.   

Abstract

Based on a pharmacophore model of the benzodiazepine binding site of the GABA(A) receptors, developed with synthetic flavones and potent 3-carbonylquinolin-4-ones, 3-alkyl- and 3-amido-6-methylisothiazoloquinolin-4-ones were designed, prepared and assayed. The suggestion that the interaction between the hydrogen bond donor site H1 with the 3-carbonyl oxygen in 3-carbonylquinolin-4-ones can be replaced by an interaction between H1 and N-2 in the isothiazoloquinolin-4-ones, was confirmed. As with the 3-carbonylquinolin-4-ones, the length of the chain in position 3 is critical for an efficient interaction with the lipophilic pockets of the pharmacophore model. The most potent 3-alkyl derivative, 3-pentyl-6-methylisothiazoloquinolin-4-one, has an affinity (K(i) value) for the benzodiazepine binding site of the GABA(A) receptors of 13 nM. However, by replacing the 3-pentyl with a 3-butyramido group an even more potent compound was obtained, with a K(i) value of 2.8 nM, indicating that the amide function facilitates additional interactions with the binding site.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22055239     DOI: 10.1016/j.bioorg.2011.10.001

Source DB:  PubMed          Journal:  Bioorg Chem        ISSN: 0045-2068            Impact factor:   5.275


  2 in total

1.  Optimum conditions of radioligand receptor binding assay of ligands of benzodiazepine receptors.

Authors:  Fatemeh Ahmadi; Sara Dabirian; Mehrdad Faizi; Sayyed Abbas Tabatabai; Davood Beiki; Soraya Shahhosseini
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

2.  Novel Derivatives of diphenyl-1,3,4-oxadiazol as Ligands of Benzodiazepine Receptors; Synthesize, Binding Assay and Pharmacological Evaluation.

Authors:  Mona Khoramjouy; Naeime Zarepishe; Elham Rezaee; Ali Imani; Rojin Mahmoudzadeh-Mandolakani; Seyedali Hashemi; Moones Fallah; Golnar Hasheminasab; Soraya Shahhosseini; Sayyed Abbas Tabatabai; Mehrdad Faizi
Journal:  Iran J Pharm Res       Date:  2021       Impact factor: 1.696

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.